Lgl Partners, LLC Aptinyx Inc. Transaction History

Lgl Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.38 - $2.58 $7,296 - $49,536	-19,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.27 - $3.62 $43,584 - $69,504	19,200 New	19,200 $44,000
Q2 2020 Aug 10, 2020	SELL	$1.99 - $4.4 $38,208 - $84,480	-19,200 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.81 - $5.03 $34,752 - $96,576	19,200 New	19,200 $41,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Lgl Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Lgl Partners, LLC with notifications on news.